 Assessment of progression will be performed by an Independent Review Committee IRC based on Response Evaluation Criteria in Solid Tumors RECIST ver. 1.1 criteria. Events signaling progression include increase in size andor number of lesions, distant or nodal disease progression, or death. All secondary endpoints involving disease response and progression will be based on the IRC determination. 